Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, December 4th:
Lam Research Corporation (LRCX - Free Report) : This manufacturer of semiconductor processing equipment, which carries a Zacks Rank #1 (Strong Buy), has witnessed the Zacks Consensus Estimate for its current year earnings increasing 15.8% over the last 60 days.
Lam Research Corporation Price and Consensus
Lam Research has a PEG ratio of 0.86, compared with 1.13 for the industry. The company possesses a Growth Score of A.
Lam Research Corporation PEG Ratio (TTM)
Chemours Company (CC - Free Report) : This provider of performance chemicals, which carries a Zacks Rank #2 (Buy), has witnessed the Zacks Consensus Estimate for its current year earnings advancing 2.8% over the last 60 days.
Chemours Company (The) Price and Consensus
Chemours Company has a PEG ratio of 0.90, compared with 1.89 for the industry. The company possesses a Growth Score of A.
Chemours Company (The) PEG Ratio (TTM)
Statoil ASA : This energy company, which carries a Zacks Rank #2 (Buy), has witnessed the Zacks Consensus Estimate for its current year earnings increasing 7.5% over the last 60 days.
Statoil ASA Price and Consensus
Statoil has a PEG ratio of 0.64, compared with 2.52 for the industry. The company possesses a Growth Score of A.
Statoil ASA PEG Ratio (TTM)
Burlington Stores, Inc. (BURL - Free Report) : This retailer of branded apparel products, which carries a Zacks Rank #2 (Buy), has witnessed the Zacks Consensus Estimate for its current year earnings increasing 1.9% over the last 60 days.
Burlington Stores, Inc. Price and Consensus
Burlington Stores has a PEG ratio of 1.46, compared with 1.59 for the industry. The company possesses a Growth Score of A.
Burlington Stores, Inc. PEG Ratio (TTM)
See the full list of top ranked stocks here
Learn more about the Growth score and how it is calculated here.
5 Medical Stocks to Buy Now
Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia, and other conditions.
New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline. Early investors could realize exceptional profits.
Click here to see the 5 stocks >>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, December 4th:
Lam Research Corporation (LRCX - Free Report) : This manufacturer of semiconductor processing equipment, which carries a Zacks Rank #1 (Strong Buy), has witnessed the Zacks Consensus Estimate for its current year earnings increasing 15.8% over the last 60 days.
Lam Research Corporation Price and Consensus
Lam Research has a PEG ratio of 0.86, compared with 1.13 for the industry. The company possesses a Growth Score of A.
Lam Research Corporation PEG Ratio (TTM)
Chemours Company (CC - Free Report) : This provider of performance chemicals, which carries a Zacks Rank #2 (Buy), has witnessed the Zacks Consensus Estimate for its current year earnings advancing 2.8% over the last 60 days.
Chemours Company (The) Price and Consensus
Chemours Company has a PEG ratio of 0.90, compared with 1.89 for the industry. The company possesses a Growth Score of A.
Chemours Company (The) PEG Ratio (TTM)
Statoil ASA : This energy company, which carries a Zacks Rank #2 (Buy), has witnessed the Zacks Consensus Estimate for its current year earnings increasing 7.5% over the last 60 days.
Statoil ASA Price and Consensus
Statoil has a PEG ratio of 0.64, compared with 2.52 for the industry. The company possesses a Growth Score of A.
Statoil ASA PEG Ratio (TTM)
Burlington Stores, Inc. (BURL - Free Report) : This retailer of branded apparel products, which carries a Zacks Rank #2 (Buy), has witnessed the Zacks Consensus Estimate for its current year earnings increasing 1.9% over the last 60 days.
Burlington Stores, Inc. Price and Consensus
Burlington Stores has a PEG ratio of 1.46, compared with 1.59 for the industry. The company possesses a Growth Score of A.
Burlington Stores, Inc. PEG Ratio (TTM)
See the full list of top ranked stocks here
Learn more about the Growth score and how it is calculated here.
5 Medical Stocks to Buy Now
Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia, and other conditions.
New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline. Early investors could realize exceptional profits.
Click here to see the 5 stocks >>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Get the latest research report on LRCX - FREE
Get the latest research report on BURL - FREE
Get the latest research report on CC - FREE